Thermo Fisher Scientific Inc.
TMO · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $4,009,000 | $8,083,000 | $8,524,000 | $4,477,000 |
| Short-Term Investments | $1,561,000 | $0 | $0 | $0 |
| Receivables | $9,626,000 | $9,664,000 | $9,427,000 | $8,945,000 |
| Inventory | $4,978,000 | $5,088,000 | $5,634,000 | $5,051,000 |
| Other Curr. Assets | $1,963,000 | $1,760,000 | $1,644,000 | $1,640,000 |
| Total Curr. Assets | $22,137,000 | $24,589,000 | $25,229,000 | $20,113,000 |
| Property Plant & Equip (Net) | $10,795,000 | $11,004,000 | $10,873,000 | $9,864,000 |
| Goodwill | $45,853,000 | $44,020,000 | $41,196,000 | $41,924,000 |
| Intangibles | $15,533,000 | $16,670,000 | $17,478,000 | $20,146,000 |
| Long-Term Investments | $560,000 | $59,000 | $155,000 | $73,000 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $2,443,000 | $2,384,000 | $2,223,000 | $3,003,000 |
| Total NC Assets | $75,184,000 | $74,137,000 | $71,925,000 | $75,010,000 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $97,321,000 | $98,726,000 | $97,154,000 | $95,123,000 |
| Liabilities | – | – | – | – |
| Payables | $3,079,000 | $2,872,000 | $3,381,000 | $2,867,000 |
| Short-Term Debt | $2,475,000 | $3,872,000 | $5,851,000 | $2,803,000 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $2,852,000 | $2,689,000 | $2,601,000 | $2,655,000 |
| Other Curr. Liab. | $4,926,000 | $4,579,000 | $5,177,000 | $5,111,000 |
| Total Curr. Liab. | $13,332,000 | $14,012,000 | $17,010,000 | $13,436,000 |
| LT Debt | $30,300,000 | $32,552,000 | $30,222,000 | $33,536,000 |
| Deferred Rev, NC | $1,138,000 | $1,499,000 | $1,179,000 | $1,238,000 |
| Deferred Tax Liab, NC | $1,268,000 | $1,922,000 | $2,849,000 | $3,837,000 |
| Other NC Liab. | $1,612,000 | $1,899,000 | $1,746,000 | $2,099,000 |
| Total NC Liab. | $34,318,000 | $37,872,000 | $35,996,000 | $40,710,000 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1,239,000 | $1,244,000 | $1,313,000 | $1,388,000 |
| Total Liabilities | $47,650,000 | $51,884,000 | $53,006,000 | $54,146,000 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $444,000 | $442,000 | $441,000 | $439,000 |
| Retained Earnings | $53,102,000 | $47,364,000 | $41,910,000 | $35,431,000 |
| AOCI | -$2,697,000 | -$3,224,000 | -$3,099,000 | -$2,329,000 |
| Other Equity | -$1,265,000 | $2,153,000 | $4,726,000 | $7,252,000 |
| Total Equity | $49,584,000 | $46,735,000 | $43,978,000 | $40,793,000 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $87,000 | $107,000 | $170,000 | $184,000 |
| Total Liab. & Tot. Equity | $97,321,000 | $98,726,000 | $97,154,000 | $95,123,000 |
| Net Debt | $28,766,000 | $28,341,000 | $27,549,000 | $31,862,000 |